What does “Asclemed USA Inc” have to do with cyanocobalamin?
“Asclemed USA Inc” appears to be a company name tied to products that include or reference cyanocobalamin (vitamin B12). Cyanocobalamin is a synthetic, stable form of vitamin B12 used as a supplement and in certain medical treatments.
Are there any patents or exclusivity issues for cyanocobalamin products tied to Asclemed USA Inc?
I don’t have enough provided information to verify which specific cyanocobalamin product(s) are associated with Asclemed USA Inc, or whether there are active patents/exclusivity specific to that company’s products.
If you share one of the following, I can narrow it down and check for relevant patent context:
- the exact product name (or NDC number)
- the strength (e.g., 1000 mcg) and dosage form (tablet, injection, etc.)
- a link to the listing where you saw “Asclemed USA Inc” mentioned
What’s the likely regulatory/commercial context for cyanocobalamin?
Cyanocobalamin is widely available, often as:
- over-the-counter or prescription vitamin B12 supplements, and/or
- generic products (depending on route, strength, and labeling).
Because cyanocobalamin itself is an established ingredient, most brand-level protections (if any) tend to be tied to specific formulations, dosage forms, or branded labeling rather than the molecule broadly.
Where you can verify product and company details
To confirm the exact product associated with Asclemed USA Inc (and then connect that to any patent records, if relevant), share the product link or NDC. If you want to research patent history more directly, DrugPatentWatch.com can be a useful starting point for drug-level patent/exclusivity lookups.